8FGQ
Structure of human endothelial nitric oxide synthase heme domain in complex with 4-(5-(2-(dimethylamino)ethyl)-2,3-difluorophenethyl)-6-methylpyrimidin-2-amine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 8.2.1 |
Synchrotron site | ALS |
Beamline | 8.2.1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2020-02-24 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1.0000 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 59.569, 151.480, 108.348 |
Unit cell angles | 90.00, 91.08, 90.00 |
Refinement procedure
Resolution | 75.785 - 2.200 |
R-factor | 0.1951 |
Rwork | 0.193 |
R-free | 0.24620 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 5uo8 |
RMSD bond length | 0.009 |
RMSD bond angle | 1.060 |
Data reduction software | MOSFLM |
Data scaling software | Aimless (0.7.4) |
Phasing software | REFMAC |
Refinement software | PHENIX (1.11.1_2575) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 75.785 | 75.740 | 2.240 |
High resolution limit [Å] | 2.200 | 12.050 | 2.200 |
Rmerge | 0.172 | 0.087 | 1.278 |
Rmeas | 0.203 | 0.102 | 1.500 |
Rpim | 0.106 | 0.052 | 0.781 |
Total number of observations | 2245 | 17286 | |
Number of reflections | 97129 | 619 | 4755 |
<I/σ(I)> | 5 | 11.5 | 1.2 |
Completeness [%] | 99.9 | 99.7 | 99.9 |
Redundancy | 3.6 | 3.6 | 3.6 |
CC(1/2) | 0.966 | 0.983 | 0.312 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 277 | 10-12% PEG3350, 0.1M BIS-TRIS 0.2-0.3M MG ACETATE, 0.1M GdCl3 10% glycerol, 5 mM TCEP |